Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-06-10
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Electrical Stimulation (NMES) Preserves Muscle Mass in Intensive Care Unit (ICU)
NCT05287919
Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia
NCT06974461
The Impact of Bed Rest, Aging and NMES on Skeletal Muscle
NCT05617222
Blood Flow Restriction Training for Age-Related Sarcopenia
NCT06986395
Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease
NCT05838911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Additionally, the control group receives a placebo treatment (being connected to a non-active neuromusculoskeletal device), which helps reduce the psychological effects of knowing they are not receiving active intervention
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neuromuscular Electrical Stimulation (NMES) Group
Participants receive neuromuscular electrical stimulation (NMES) targeting the quadriceps and hamstrings, 30 minutes per session, 3 times per week for 8 weeks
Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group
NMES Group: Receives neuromuscular electrical stimulation to the thigh muscles for 30 minutes, three times per week, over 8 weeks.
Resistance + BFR Group: Performs low-load resistance exercises with blood flow restriction applied to the thighs, also for 30 minutes per session, three times per week, over 8 weeks.
Control Group: Receives placebo treatment using a turned-off stimulation device with no active intervention during the 8-week period.
Resistance + BFR Group
Participants perform low-load resistance training (30% 1RM) combined with blood flow restriction using pneumatic cuffs, 30 minutes per session, 3 times per week for 8 weeks
Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group
NMES Group: Receives neuromuscular electrical stimulation to the thigh muscles for 30 minutes, three times per week, over 8 weeks.
Resistance + BFR Group: Performs low-load resistance exercises with blood flow restriction applied to the thighs, also for 30 minutes per session, three times per week, over 8 weeks.
Control Group: Receives placebo treatment using a turned-off stimulation device with no active intervention during the 8-week period.
Control Group
Participants receive placebo treatment by being connected to a neuromusculoskeletal device that is turned off (no actual stimulation), with no active intervention during the 8-week period
Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group
NMES Group: Receives neuromuscular electrical stimulation to the thigh muscles for 30 minutes, three times per week, over 8 weeks.
Resistance + BFR Group: Performs low-load resistance exercises with blood flow restriction applied to the thighs, also for 30 minutes per session, three times per week, over 8 weeks.
Control Group: Receives placebo treatment using a turned-off stimulation device with no active intervention during the 8-week period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group
NMES Group: Receives neuromuscular electrical stimulation to the thigh muscles for 30 minutes, three times per week, over 8 weeks.
Resistance + BFR Group: Performs low-load resistance exercises with blood flow restriction applied to the thighs, also for 30 minutes per session, three times per week, over 8 weeks.
Control Group: Receives placebo treatment using a turned-off stimulation device with no active intervention during the 8-week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Low muscle strength (e.g., low handgrip strength)
Low muscle mass (e.g., ASM/height² below cutoff)
Exclusion Criteria
* kidny disese
* autoimune disese
* cognetive disorder
* sever form of sarcopenia
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pharos University in Alexandria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ola Mohamed Elsayed Elgohary
ola mohamed elsayed elgohary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sarcopenia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.